In multivariate analyses conducted in a CIBMTR study, it was revealed that DDX11 mutations affect survival by increasing the risk of both relapse and transplant-related mortality in patients with myelodysplastic syndrome [35]. Here, DDX11 is linked to myelodysplastic syndrome.